New stem cell approach targets functional cure for diabetes - News-Medical
Researchers are advancing a new cell therapy for Type 1 diabetes, utilizing immune-engineered cells to eliminate the need for immunosuppression.
📍 How it ended
Researchers initiated human trials to evaluate immune-engineered cell therapies for the treatment of type 1 diabetes. Sana Biotechnology subsequently released published data highlighting the durability of hypoimmune-modified islet cell transplantation without the need for immunosuppression.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 46d ago, after coverage quieted.
Questions people are asking
What is the primary goal of this new cell therapy?
The research aims to treat Type 1 diabetes using immune-engineered cells, potentially providing a functional cure that removes the requirement for immunosuppressive drugs.
What data has been released regarding the treatment?
According to reports in The New England Journal of Medicine, new data demonstrates the long-term durability of hypoimmune-modified islet cell transplantation.
Which organization is leading this development?
Sana Biotechnology is the organization associated with the cell therapy and the related publication in The New England Journal of Medicine.
What happened
New clinical research is exploring a functional cure for Type 1 diabetes through the transplantation of immune-engineered stem cells. The approach focuses on enabling these transplanted cells to thrive within the body while avoiding rejection.
Coverage from outlets including Bioengineer.org, News-Medical, and The Manila Times highlights the release of long-term data published in The New England Journal of Medicine. Reports indicate that Sana Biotechnology is presenting findings regarding the durability of these hypoimmune-modified islet cell transplants.
Observers are looking toward the upcoming European Association for the Study of Diabetes (EASD) meeting, where further updates on the therapy are expected. Coverage does not yet specify the full scope of patient outcomes from the ongoing human trials.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 47d ago.
Coverage (5)
- First Human Trial Explores Immune-Engineered Cell Therapy for Type 1 Diabetes Bioengineer.org · 50d ago
- Sana Biotech heads to EASD with diabetes cell therapy update Longevity.Technology · 50d ago
- New Research Seeks to Help Transplanted Cells Thrive in Type 1 Diabetes Treatment Newswise · 50d ago
- Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 D The Manila Times · 50d ago
- New stem cell approach targets functional cure for diabetes News-Medical · 50d ago
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Science Says This Workout Can Make Your Body 8 Years Younger. A Trainer Explains How to Do It
New research and expert guidance are centering on strength training as a primary factor in longevity and physical health.
Research Shows a Certain Amount of Strength Training Every Week Can Help You Live Longer
New research suggests a correlation between weekly strength training and increased longevity, alongside potential benefits for brain and heart health.
Heat wave warning: Common medications that can increase your risk of heat illness
Medical professionals are issuing warnings regarding how common medications can increase heat-related health risks during high-temperature events.
Derivation of functional retinal endothelial cells from human pluripotent stem cells for therapeutics and modelling
Researchers have successfully derived functional retinal endothelial cells from human pluripotent stem cells, creating new avenues for vision restoration.
Strange Side Effect Found Among Ozempic Users—and It Has to Do With Smell and Taste
Medical reports are highlighting emerging accounts of taste and smell disturbances among users of GLP-1 medications like Ozempic and Mounjaro.
Two patients with severe autoimmune disease remain relapse-free for over 15 years after stem cell transplant
Two patients with severe autoimmune disease have remained free of relapses for over 15 years following a stem cell transplant.